Cipla

The company said that it is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number -…

Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01…

Its total revenue from operations rose to Rs 5,810 crore for the third quarter compared to Rs 5,479 in the year-ago period, Cipla…

A collaboration agreement is signed concurrently with the definitive agreement, which paves a path to market Ethris’s innovative…

The company started its investment journey on the automation front two years ago ,and has already been recognised for its work by…

The US FDA may continue to withhold product approvals from this facility till the outstanding observations are resolved

The company has been on an acquisition spree in recent months, from buying supplement maker Endura Mass to stake purchases in…

The plant demonstrates advanced technologies to drive productivity, workforce engagement, sustainability and resilience across 22…

Cipla's Lenalidomide capsules are therapeutic equivalent generic version of Bristol Myers Squibb's Revlimid (Lenalidomide)…

The recall has taken place due to manufacturing issues